Salmonella Gallinarum 9R Vaccine Strain from LAVETEC Cia. LTDA
This project involves the molecular characterization of the Salmonella Gallinarum 9R vaccine strain produced by LAVETEC, which is a commercial vaccine. The aim is to analyze and understand the genetic composition of this strain to identify key molecular markers and features that contribute to its efficacy. By studying its genome, we seek to enhance our knowledge of the vaccine and support its continued use in improving animal health